Home » Newsletters » BioWorld Science

BioWorld Science

March 3, 2015

View Archived Issues

Initiation of clinical trial of TLR7 agonist GS-9620 in HIV-positive patients on ART

ISA Pharmaceuticals begins first phase I/II trial of Amplivant conjugates

Biogen Idec and Sobi report topline data from phase III Alprolix pediatric trial

Johnson & Johnson Health and Wellness Solutions formed to encourage well-being and quality of life

Cipher Pharmaceuticals acquires three dermatology products from Astion Pharma

New N-type calcium channel blockers disclosed by Janssen

Investigators at Duke University divulge new LpxC inhibitors

Pacira receives FDA complete response letter for Exparel sNDA

Cadila Healthcare patents new JAK inhibitors

Boehringer Ingelheim discloses new ENaC blockers

Russian and U.S. investigators present new adenosine A2A receptor antagonists

Phase II data lead to phase III initiation for HIV candidate BMS-663068

Abraxane approved by European Commission for first-line treatment of NSCLC

FDA accepts Alexion's BLA for asfotase alfa in hypophosphatasia for priority review

EMA committee recommends approval of Avastin plus chemotherapy for advanced cervical cancer

European Commission approves Xydalba for ABSSSI

Tenofovir alafenamide fumarate subject of several presentations at CROI

Shire submits NDA for lifitegrast for dry eye

Taiho seeks European approval for TAS-102 for metastatic colorectal cancer

FDA accepts for filing Xadago NDA

New clinical trial evaluates ZMapp for Ebola virus

Envelope-specific monoclonal antibodies offer a novel approach for the treatment of HIV infection

Torii gains rights from Japan Tobacco to market Gilead tenofovir alafenamide combinations in Japan

Boehringer Ingelheim files for approval of dabigatran antidote idarucizumab

FDA accepts sBLA for Yervoy in stage III melanoma

CHMP recommends approval of Humira for severe chronic plaque psoriasis in children

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...